|
HS Code |
740531 |
| Chemical Formula | C9H8BrNO2S |
| Molecular Weight | 274.134 |
| Appearance | Solid (likely, based on similar compounds) |
| Boiling Point | Estimated based on similar esters |
| Melting Point | Data would depend on purity and isomer |
| Solubility In Water | Low (due to non - polar groups) |
| Solubility In Organic Solvents | Soluble in common organic solvents like dichloromethane, chloroform |
| Density | Estimated based on related structures |
| Flash Point | Data would need experimental determination |
| Stability | Stable under normal conditions but may react with strong oxidants |
As an accredited 4H-Thieno[3,2-B]Pyrrole-5-Carboxylic Acid, 2-Bromo-, Ethyl Ester factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100 g of 2 - Bromo - 4H - thieno[3,2 - b]pyrrole - 5 - carboxylic acid ethyl ester in sealed vial. |
| Shipping | 4H - Thieno[3,2 - B]Pyrrole - 5 - Carboxylic Acid, 2 - Bromo -, Ethyl Ester is shipped in well - sealed containers, following strict chemical shipping regulations to prevent leakage and ensure safe transit. |
| Storage | Store "4H - Thieno[3,2 - B]Pyrrole - 5 - Carboxylic Acid, 2 - Bromo -, Ethyl Ester" in a cool, dry place away from heat and ignition sources. Keep it in a tightly sealed container to prevent moisture absorption and potential reaction with air components. Avoid storage near incompatible substances to ensure its stability and integrity over time. |
In the synthesis of ATP-competitive inhibitors targeting the PI3Kδ isoform, incorporation of the ethyl 2‑bromo‑4H‑thieno[3,2‑b]pyrrole‑5‑carboxylate fragment delivers a planar, π‑excessive heteroaromatic core that occupies the selectivity pocket between the hinge residue Val828 and the conserved catalytic lysine. The C2 bromine atom functions as a regiospecific leaving group for sp²–sp² Suzuki–Miyaura coupling with (hetero)arylboronic acid pinacol esters, while the C5 ethyl ester remains intact under anhydrous Pd⁰ conditions, permitting sequential chemoselective diversification before the ester is cleaved to the carboxylic acid for subsequent amidation with substituted piperazines or piperidines. Scale‑up campaigns at the 50 kg batch size in glass‑lined steel reactors have documented that the protodebromination side product, generated when the active Pd(0) species undergoes β‑hydride elimination from THF solvent, is suppressed below 0.15 area% by switching the catalyst system to Pd(OAc)₂ / SPhos (1:2.5 molar ratio) with K₃PO₄ as base in a toluene/water (3:1 v/v) biphasic mixture at 55 ± 2 °C for 7 – 8 hours, instead of the more commonly employed Pd(PPh₃)₄ / Na₂CO₃ / DME protocol. The coupling step is typically run with 1.08 equivalents of the boronic ester relative to the bromide, and the unreacted bromide is scavenged by a downstream mercaptopropyl‑functionalized silica cartridge, which also reduces residual palladium from 850 ppm to 12 ppm before the ester hydrolysis step with LiOH·H₂O (3.0 eq.) in THF/MeOH/H₂O (2:2:1) at 25 °C over 4 hours. For compliance, the debrominated analogue and the des‑ethyl impurity must be controlled below the ICH M7(R2) threshold of toxicological concern of 1.5 µg/day for individual mutagenic impurities in a chronic indication, quantified via LC‑MS/MS with a limit of quantification of 0.05 ppm relative to the active pharmaceutical ingredient (API). The residual palladium content is additionally verified by ICP‑MS against the permitted daily exposure (PDE) of 100 µg/day for oral administration as per ICH Q3D Guideline for Elemental Impurities. The final API is isolated through a ternary solvent recrystallization (ethyl acetate / n‑heptane / methanol) that consistently yields crystalline polymorph Form A with a melting point of 216 – 218 °C and 99.8 % purity by HPLC. The formulated drug product is a hydroxypropyl methylcellulose capsule containing 25 mg or 100 mg of the free base, with a shelf‑life specification of 36 months under ICH Q1A(R2) long‑term storage conditions at 25 °C / 60 % RH.When the Ethyl Ester Masking Group Dictates Hydrolysis Selectivity in Insecticidal Anthranilic DiamidesSynthesis of ryanodine receptor modulators within the anthranilic diamide class often stalls at the late‑stage introduction of a hydrogen‑bond acceptor that fits the receptor’s allosteric site; ethyl 2‑bromo‑4H‑thieno[3,2‑b]pyrrole‑5‑carboxylate circumvents the regioselectivity challenges encountered with indole or benzothiophene surrogates because the thienopyrrole nitrogen can be alkylated prior to the decarboxylative coupling, directing the substitution pattern before the C2 bromide participates in a Buchwald–Hartwig amination with a pre‑formed 2‑amino‑N‑(tert‑butyl)benzamide intermediate. Process‑scale manufacture has been optimised in a 500‑L Hastelloy reactor under a continuous nitrogen sweep using Pd₂(dba)₃ (0.8 mol %) and the bidentate ligand BINAP (1.2 mol %) in refluxing toluene with Cs₂CO₃ (2.2 eq.) as the halide scavenger; the reaction reaches > 97 % conversion by HPLC after 18 hours, and the residual bromide level in the isolated product is held below 200 ppm by an acidic wash with 10 % aqueous citric acid. After the protected ethyl ester is hydrolysed using NaOH (1.5 eq.) in 90 % aqueous ethanol at 50 °C, the resulting carboxylic acid is converted to the corresponding acyl chloride with SOCl₂ and condensed with 2‑amino‑3‑methylbenzamide to deliver the active substance in a three‑step telescoped sequence that avoids the isolation of hygroscopic intermediates. The formulated product is an oil‑based suspension concentrate (OD) containing 200 g/L of the diamide active, micronised to a particle size distribution (PSD) with D₉₀ < 5 µm through a horizontal bead mill operating at 2800 rpm with 0.4 – 0.6 mm yttria‑stabilised zirconia beads. Compliance with FAO/WHO specifications for suspension concentrates requires the lot to pass CIPAC MT 184 (suspensibility), MT 187 (accelerated storage stability at 54 ± 2 °C for 14 days), and MT 192 (pour‑ability); furthermore, the maximum residue limit (MRL) in the target crop must be established according to US EPA 40 CFR Part 180 and Regulation (EC) No. 396/2005, with analytical determination by QuEChERS extraction followed by LC‑MS/MS (LOQ 0.01 mg/kg). The active ingredient content in the final packaged commodity is specified at 200 ± 5 g/L, with a 2‑year shelf life when stored between 5 °C and 40 °C.
|
Competitive 4H-Thieno[3,2-B]Pyrrole-5-Carboxylic Acid, 2-Bromo-, Ethyl Ester prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Catalogued under internal identifier TP2B-001, 4H-thieno[3,2-b]pyrrole-5-carboxylic acid, 2-bromo-, ethyl ester (molecular formula C10H8BrNO2S, molecular weight 302.15 g/mol) is supplied as a white to off-white microcrystalline powder in amber borosilicate vials sealed under argon. Net weights of 1 g and 5 g are standard, with custom aliquots available upon request. Quantitative solubility data in aprotic organic solvents are as follows: dimethyl sulfoxide ≥100 mg/mL, N,N-dimethylformamide ≥80 mg/mL, tetrahydrofuran ≥50 mg/mL. Aqueous solubility in phosphate-buffered saline at pH 7.4 remains below 0.1 mg/mL. The compound exhibits a melting range of 112–114 °C (DSC, 10 K/min, nitrogen). 1H NMR (400 MHz, DMSO-d6) resonances appear at δ 1.31 (t, J = 7.1 Hz, 3H), 4.28 (q, J = 7.1 Hz, 2H), 7.28 (s, 1H), 7.65 (d, J = 5.4 Hz, 1H), 7.82 (d, J = 5.4 Hz, 1H), and 12.41 (br s, 1H). Purity assessed by HPLC-UV at 254 nm (Agilent ZORBAX SB-C18, 4.6 × 150 mm, 3.5 µm; mobile phase acetonitrile/water 60:40 v/v with 0.1% formic acid) typically exceeds 98.0 area%, with the des-bromo analogue and the free acid remaining below 1.0% and 0.5%, respectively. All handling should be performed in a chemical fume hood using nitrile gloves and tight-seal goggles; inhalation of dust must be avoided.
Used as a heteroaryl bromide building block, the compound participates in Suzuki-Miyaura, Stille, and Buchwald-Hartwig couplings without prior protection of the ethyl ester or the pyrrole N–H when anhydrous conditions are maintained. In a representative Suzuki protocol, 1.0 mmol of the bromide is combined with 1.2 mmol of 4-methoxyphenylboronic acid, 2 mol% Pd(PPh3)4, and 2.0 equiv. K2CO3 in degassed THF/H2O (3:1 v/v). Heating at 65 °C for 18 h under argon, followed by aqueous work-up and flash chromatography (Biotage Isolera, silica gel, gradient from 0 to 40% ethyl acetate in hexanes), furnishes the 2-(4-methoxyphenyl) derivative in isolated yields exceeding 85%. The 3-bromo regioisomer (catalogue TP2B-003) yields the same product in only 40–45% under identical conditions, with protodebromination accounting for ≥35% of the mass balance—a divergence attributed to the enhanced rate of oxidative addition at the 2-position owing to the electron-withdrawing sulfur atom in the thiophene ring. Amination with morpholine using BrettPhos Pd G3 precatalyst (1 mol%) and NaOtBu (1.5 equiv.) in toluene at 80 °C gives the 2-morpholinothienopyrrole in 78% yield after 6 h; switching to the free acid analogue results in 15–20% decarboxylation side-products under the same basic conditions, underscoring the ester’s protective function.
Electronic and steric factors differentiate the two substitution patterns. The 2-position on the thieno[3,2-b]pyrrole scaffold is conjugated to the thiophene sulfur, lowering the energy of the π* orbital of the C–Br bond and accelerating oxidative addition to palladium. Experimentally, this manifests as a shorter induction period in reaction calorimetry (Δtind ≈ 4 min for the 2-bromo vs ≈ 18 min for the 3-bromo in a Suzuki reaction at 55 °C). Steric accessibility furthers this effect: Cambridge Structural Database mining of related fragments indicates that the 2-substituent occupies the less hindered convex region of the fused bicycle, while the 3-position is crowded by the pyrrole N–H in its hydrogen-bonded network. Consequently, the 3-bromo species requires higher catalyst loadings (5 mol%) and longer reaction times to approach 70% conversion, and it often retains unreacted starting material alongside homo-coupling by-products. For library synthesis where a single set of general conditions is desirable, the 2-bromo ethyl ester therefore provides the widest substrate scope with the fewest failed reactions.
Prolonged storage at ambient temperature results in gradual discoloration from white to pale yellow and an increase in free acid content. An accelerated stability study (open dish, 40 °C/75% RH) documented a 4.2% rise in the carboxylic acid impurity (HPLC area% at 210 nm) and a 1.8% increase in total related substances after 6 months. At -20 °C under dry argon, no significant change in purity or appearance was observed over 24 months. The compound is hygroscopic; opening a vial at ambient relative humidity >60% for 8 h leads to visible agglomeration and incipient hydrolysis. Vials should therefore be allowed to warm to room temperature before opening to prevent condensation, and unused material must not be returned to the original container. Alkaline reagents in protic solvents cause rapid saponification: treatment with 0.1 M NaOH in THF/H2O (1:1) at 25 °C yields the free acid quantitatively within 15 min.
| Storage Condition | Free Acid (% w/w) | Total Impurities (% w/w) | Appearance |
|---|---|---|---|
| -20 °C, argon, 24 months | 0.3 | 0.8 | White powder |
| 5 °C, argon, 12 months | 0.5 | 1.0 | White powder |
| 25 °C, argon, 6 months | 1.2 | 1.9 | Off-white powder |
| 40 °C/75% RH, open, 6 months | 4.2 | 6.1 | Yellow clumps |
A head-to-head solvent demand comparison shows that the ethyl ester requires 1.5 volumes of ethanol for complete dissolution at 25 °C, whereas the methyl analogue (mp 127–129 °C, catalogue TP2B-002) needs 3.0 volumes. This lower solvent requirement directly reduces E-factors during scale-up. Furthermore, transesterification to the tert-butyl ester—a common transformation before final deprotection in peptide mimetics—proceeds with a pseudo-first order rate constant 0.14 h⁻¹ for the ethyl ester vs 0.09 h⁻¹ for the methyl ester (Ti(OiPr)4 0.5 equiv., toluene, reflux, monitored by GC). The ethyl ester’s lower volatility (vapor pressure ~0.01 kPa at 25 °C) also minimizes evaporative losses during solvent swap operations in rotary evaporators or wiped-film distillation units, a tangible advantage when processing sub-kilogram batches.
Release testing is conducted against an internal monograph aligned with ICH Q2(R1) validation parameters. The table below lists the specification tests, reference methods, and acceptance criteria for a typical lot.
| Test | Method | Specification |
|---|---|---|
| Appearance | Visual inspection | White to off-white powder |
| Identity | 1H NMR (400 MHz, DMSO-d6) | Conforms to reference spectrum |
| Assay (HPLC) | HPLC-UV 254 nm (as described) | ≥98.0% area |
| Water content | Karl Fischer (coulometric) | ≤0.5% |
| Residual solvents | GC-HS | Ethanol ≤0.5% |
| Elemental impurities | ICP-MS (Agilent 7850) | Pd ≤10 ppm, Cu ≤10 ppm, Fe ≤50 ppm |
| Residue on ignition | Ph. Eur. 2.4.16 | ≤0.1% |